Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NKGen Biotech, Inc. Nyse

Equities

NKGN

US65488A1016

Market Closed - Nyse
Other stock markets
 16:00:00 2024-06-17 EDT 		5-day change 1st Jan Change
1.29 USD -4.44% Intraday chart for NKGen Biotech, Inc. -9.79% -84.46%
06-12 NKGen Biotech, Inc. Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 CI
06-03 NKGen Biotech, Inc. To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MODERNA, INC. Stock Moderna, Inc.
 52.85B -
LONZA GROUP AG Stock Lonza Group AG
 38.24B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.87B
CELLTRION, INC. Stock Celltrion, Inc.
 26.79B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.16B
  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. NKGN Stock
  5. Charts NKGen Biotech, Inc.
  6. Sector Chart